Skip to main content


Generic name: lidocaine hydrochloride monohydrate
Drug class: Topical anesthetics

Medically reviewed by Last updated on Aug 23, 2023.

What is Zingo?

Zingo is an amide local anesthetic indicated for use on intact skin to provide local analgesia prior to venipuncture or peripheral intravenous cannulation in children 3-18 years of age.

Important Limitations:

Zingo Dosage and Administration

Dosage Forms and Strengths

Zingo is a sterile, single-use, powder intradermal injection system containing 0.5 mg lidocaine hydrochloride monohydrate.

Zingo utilizes a helium-powered delivery system.

Zingo Contraindications

Zingo is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type.

Zingo Warnings and Precautions

Zingo Adverse Reactions

The most common adverse reactions (>5%) are skin reactions at the site of administration: erythema, petechiae, edema.

To report Suspected Adverse Reactions, contact Anesiva, Inc. at 1-650-624-9600 or FDA at 1-800-FDA-1088 or

Instructions for Use

How Supplied / Storage and Handling

Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system contains 0.5 mg of sterile lidocaine hydrochloride monohydrate. Zingo is a singleuse device packaged in an individual foil/clear pouch placed inside a bubble-wrap sleeve. Twelve sleeves are placed in labeled cartons. Cartons are stored at controlled room temperature (15 - 30C, 59-86F).

Patient Counseling Information

Patients should be made aware that a sound similar to that of a popping balloon is emitted at the time Zingo is actuated. Patients should be informed that skin reactions including erythema, petechiae and edema may occur.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.